Dr. Lasse Leino, CEO at DelSiTech.
Turku, Finland – 30th August 2024: DelSiTech Ltd, a clinical stage Finnish drug delivery and drug development company, today announced receiving of the Entrepreneurial Spirit of Turku “Growth in Sight” award as part of the Turku Europe Forum Event 2024.
In the Growth in Sight category, the recipient company’s operations have to predict future growth. The company uses its own operations to create growth and development opportunities for other companies as well. Their growth concept also acts as a bold example for those looking to start new companies.
In its reasoning, the Award Committee concluded that DelSiTech has focused on rapid business growth, and it has a strong commitment to grow further. This is demonstrated, among others, by a large increase in company headcount, double-digit growth in revenues for many years as well as multiple high value technology licensing deals, the latest signed in May 2024 with a total deal value of over 200 million EUR.
Dr. Lasse Leino, CEO of DelSiTech said, “We are honoured to be recognized for our continuing efforts to grow as a company and expand our business worldwide. DelSiTech received earlier in 2020 the Entrepreneurial Spirit of Turku “Born Global” award which recognized our international standing in South-West Finland area. Now, along with this second award DelSiTech has moved to the next level as an established growth company. This recognition from our hometown is truly motivating and inspiring.”